The DOI matches its Crossref record.
Specific activation of the non‐classical class I histocompatibility HLA‐G antigen and expression of the ILT2 inhibitory receptor in human breast cancer
Abstract
The HLA‐G molecule is a non‐classical HLA class I antigen selectively expressed by trophoblastic cells that invade the maternal decidua during human pregnancy. HLA‐G is believed to contribute to tolerance of the semi‐allogeneic fetus by inhibiting maternal immune responses. Similarly, HLA‐G expression in tumour cells may favour their escape from host immune surveillance. This study investigated HLA‐G expression in human mammary tumours. Immunohistochemical analysis of cryo‐preserved and paraffin‐embedded breast tissue biopsies, using two HLA‐G‐specific antibodies, revealed that unlike non‐cancerous breast tissue in the vicinity of the tumour, 14 out of 36 breast cancer lesions selectively expressed HLA‐G. HLA‐G expression was significantly more frequent in lesions that were highly infiltrated by host immune cells, thus correlating HLA‐G activation with inflammation. Further histological and double‐staining immunofluorescence analysis attributed HLA‐G expression mainly to tumour epithelial cells and to subsets of infiltrating CD68+ and CD8+ cells. RT‐PCR analysis suggested that HLA‐G was activated at the transcriptional level in breast tumours. The presence of ILT2 (Ig‐like transcript 2) killing inhibitory receptors known to interact with HLA‐G was also demonstrated in host immune cells that infiltrate breast cancer lesions. These results indicate that HLA‐G is up‐regulated at high frequencies in human breast cancer, where it may impair efficient anti‐tumour immunity. Copyright © 2001 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. J., Makadzange, A., Rowland-Jones, S., Willcox, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431057100 · Cited by 557
Carosella, E. D., Rouas-Freiss, N., Roux, D. T.-L., Moreau, P., & LeMaoult, J. (2015) · Advances in Immunology · doi:10.1016/bs.ai.2015.04.001 · Cited by 395
Self-citationHLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
CAROSELLA, E. D., MOREAU, P., LE MAOULT, J., LE DISCORDE, M., DAUSSET, J., & ROUAS-FREISS, N. (2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81006-4 · Cited by 371
Self-citationHLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells
Lemaoult, J., Zafaranloo, K., Le Danff, C., & Carosella, E. D. (2005) · The FASEB Journal · doi:10.1096/fj.04-1617fje · Cited by 302
Self-citationThe LILR family: modulators of innate and adaptive immune pathways in health and disease
Brown, D., Trowsdale, J., & Allen, R. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00290.x · Cited by 291
Metadata
- Authors
- Lefebvre, S., Antoine, M., Uzan, S., McMaster, M., Dausset, J., Carosella, E. D., & Paul, P.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2001-12-18
- Volume
- 196
- Issue
- 3
- Pages
- 266-274
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2069197942
- Cited by
- 186
- References
- 0
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specific activation of the non‐classical class I histocompatibility HLA‐G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. https://app.cochat.ai/papers/10.1002/path.1039
- The paper
- Lefebvre, S., Antoine, M., Uzan, S., McMaster, M., Dausset, J., Carosella, E. D., & Paul, P. (2002). Specific activation of the non‐classical class I histocompatibility HLA‐G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. The Journal of Pathology. https://doi.org/10.1002/path.1039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.